Wednesday, July 8, 2026

Drug profile · INN

citric acid

citric acid (UROLOGIC G IN PLASTIC CONTAINER) is an FDA-listed pharmaceutical active ingredient. Associated with United Therapeutics Europe Ltd. Route of administration: irrigation. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 20
Pipeline programs 2
News articles 0
Drug details — citric acid
US status
approved
Class
Route
IRRIGATION
Patents
20
Programs
2
Data quality
0.89

Quick answer

citric acid (UROLOGIC G IN PLASTIC CONTAINER) is an FDA-listed pharmaceutical active ingredient. Associated with United Therapeutics Europe Ltd. Route of administration: irrigation. Current US regulatory status: approved.

Key facts

INN citric acid
Brand UROLOGIC G IN PLASTIC CONTAINER
Route IRRIGATION
Formulation SOLUTION

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. AERD-COV19 Phase 3 · COLLEGIUM PHARMACEUTICAL · aspirin-exacerbated respiratory disease
  2. UIC-BKL-2013 Phase 3 · Universal Integrated · Bowel Preparation Before Colonoscopy
  1. US 12415845

    Methods of producing T cell populations using hydroxycitric acid and/or a salt thereof

    Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 12383500

    Nanoliposome compositions and methods of using the same

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 12384820

    Griffithsin mutants

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 12383618

    Expression vector delivery system and use thereof for inducing an immune response

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 12383554

    Compositions and methods to protect mammalian tissue against cold and other metabolic stresses

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 12350274

    Nucleotide analogs

    Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 12343432

    Encapsulated probiotic

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 12336974

    Methods and compositions for preventing and treating auditory dysfunctions

    Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 12325688

    Gingerenone A prodrugs as sensotherapeutics and methods of use

    Expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 12298315

    Systems and methods to identify and treat subjects at risk for obstetrical complications

    Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 12286657

    Methods and compositions

    Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 12281060

    Remodilins for airway remodeling and organ fibrosis

    Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 12281336

    Chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E1, and E2 structural proteins

    Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 12275758

    Prefusion RSV F proteins and their use

    Expires Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 12269803

    Krüppel-like factor 15 (KLF15) small molecule agonists in kidney disease

    Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 12268749

    Cell-penetrating peptides

    Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 12239654

    Compounds and methods for treating neurological and cardiovascular conditions

    Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 12226423

    Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide

    Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 12215164

    Immunotoxins with albumin binding domain

    Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 12214031

    Mannheimia haemolytica vector

    Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is citric acid?

citric acid (UROLOGIC G IN PLASTIC CONTAINER) is an FDA-listed pharmaceutical active ingredient. Associated with United Therapeutics Europe Ltd. Route of administration: irrigation. Current US regulatory status: approved.

What is the brand name for citric acid?

UROLOGIC G IN PLASTIC CONTAINER is a marketed brand name for citric acid. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of citric acid?

citric acid has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.